Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 743

Get the latest international news and world events from around the world.

Log in for authorized contributors

‘Lost City’ deep in the Atlantic is like nothing else we’ve ever seen on Earth

The reality of what lies within our oceans has fascinated people since time immemorial, so it’s no wonder we’ve created countless myths about the watery depths.

But step aside, Atlantis, scientists have discovered a real Lost City beneath the waves, and this one is teaming with life.

The rocky, towering landscape is located west of the Mid-Atlantic Ridge mountain range, hundreds of metres below the surface of the Atlantic Ocean, and consists of massive walls, columns and monoliths stretching more than 60 metres (200ft) tall.

Researchers teach LLMs to solve complex planning challenges

A new large language model framework teaches LLMs to use an optimization solving algorithm to resolve complex, multistep planning tasks. With the LLMFP framework, someone can input a natural language description of their problem and receive a plan to reach their desired goal.

Arlington venture capital firm debuts $32M fund for cybersecurity startups

An Arlington-based venture capital firm has announced it will pour $32 million in funding into cybersecurity startups.

Runtime Ventures, based out of Arlington and Austin, Texas, officially announced the capital commitment today (Wednesday).

It has already made 11 investments from the fund so far, supporting seed-stage cybersecurity companies focused on domains including code analysis, fraud protection, threat detection and browser security.

Atsena raises $150M for ocular gene therapies with Bain, Sofinnova in tow

Atsena Therapeutics has raised $150 million in an oversubscribed series C financing, with hopes that the funds can carry the biotech’s gene therapy designed to reverse or prevent blindness through a potential market approval.

The funding round was led by new investor Bain Capital, with participation from Sofinnova Investments, Abingworth, Wellington Management, Lightstone Ventures, Foundation Fighting Blindness, Hatteras Venture Partners, Osage University Partners and the Manning Family Foundation, according to an April 2 release.

30 Years Younger & Telomere Extension? Could Short Chains of Amino Acids Revolutionize Anti-aging?

Could Short Chains of Amino Acids Revolutionize Anti-aging? We explore the exciting potential of peptide therapy to address key hallmarks of aging, including biological age and telomere length. This video delves into the science behind peptides and examines early clinical findings that suggest significant possibilities for age reversal.

What you’ll learn:
• Key peptides being studied for anti-aging (Epitalon, GHK-Cu, etc.).
• A look at clinical studies and patient data.
• The future of peptide therapy in longevity research.

Credits to : glycanage, dr. luis martinez of clinical peptide society

Please note that the links below are affiliate links, so we receive a small commission when you purchase a product through the links. Thank you for your support!
=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=
☑ ProHealth, RENUE, DoNotAge, StemRegen, N1O1, NOVOS ☑ Coupon CODE: REVERSE

Activate Your Stem Cells Naturally — STEMREGEN 15% OFF https://tinyurl.com/StemRelease.

📒Dr Bryan Nitric Oxide Supplement 📒20% OFF Code LAFIRE

Continue reading “30 Years Younger & Telomere Extension? Could Short Chains of Amino Acids Revolutionize Anti-aging?” | >